Jacob Chacko - PRESIDENT AND CEO, Director at Oric Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Stock Symbol
ORIC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jacob Chacko - trading volume in the past year for Oric Pharmaceuticals, Inc.

Holdings reported by Jacob Chacko for Oric Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 531K $6.55M $12.32 Oct 6, 2025 Direct
Restricted Stock Unit 100K $828K $8.28 Jan 2, 2025 Direct Common Stock
Stock Option (right to buy) 600K Jan 2, 2025 Direct Common Stock

Transactions reported by Jacob Chacko for Oric Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.